Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Director/PDMR Shareholding

30 Oct 2024 10:42

RNS Number : 2460K
MJ Gleeson PLC
30 October 2024
 

MJ GLEESON plc

Incorporated in England and Wales

Registration number: 09268016

LEI: 21380064K7N2W7FD6434

ISIN: GB00BRKD9Z53

 

 

30 October 2024

 

MJ Gleeson Plc

("the Company")

 

Performance Share Plan award to Directors and PDMRs

 

The Company announces that on 28 October 2024 under the Company's Long Term Incentive Plan (the "Plan"), that the Directors and Persons Discharging Management Responsibilities ("PDMR") listed below were granted nil-cost share options ("Option") over a total of 482,362 Ordinary shares of 2p each in the Company ("Shares").

 

DIRECTOR / PDMR

Number of Shares subject to Option

Graham Prothero (Chief Executive Officer)

139,964

 

Stefan Allanson (Chief Financial Officer)

87,034

 

Mark Knight (Chief Executive, Gleeson Homes)

53,453

 

Leanne Johnson (Company Secretary)

4,949

 

 

Each Option was granted pursuant to the Plan approved by shareholders in December 2016 and amended by the Board in accordance with paragraph 19.2 of the Plan, in September 2023.

 

No consideration was paid for the grant of the Options. The number of Shares subject to each Option was calculated based on a share price of 608p, being the mid-market closing price, as derived from the London Stock Exchange daily Official List, for dealings on 25 October 2024.

 

Vesting of each Option is conditional upon achieving certain performance targets over the three-year performance period ending 30 June 2027. For Graham Prothero and Stefan Allanson, these targets will be disclosed in the Company's FY24 Annual Report and, to the extent vested, the Options will not normally become exercisable until the Company announces its financial results for the financial year ending 30 June 2029. 

 

 

Enquiries:

 

Leanne Johnson

Head of Legal and Company Secretary

MJ Gleeson plc

 

 

 

Tel: 01142 612 900

 

 

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the UK Market Abuse Regulation.

1.

Details of PDMR / person closely associated with them ('CAP')

a)

First Name

Graham

 

b)

Last Name

Prothero

 

2.

Reasons for the notification

a)

Position / status

Chief Executive Officer

 

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

MJ Gleeson Plc

 

b)

Legal Entity Identifier code

21380064K7N2W7FD6434

 

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of £0.02 each

GB00BRKD9Z53

b)

Nature of the transaction

Grant of Options over Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

Nil

139,964

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transaction

e)

Date of the transaction

28 October 2024

 

f)

Place of the transaction

Off market

 

 

1.

Details of PDMR / person closely associated with them ('CAP')

a)

First Name

Stefan

 

b)

Last Name

Allanson

 

2.

Reasons for the notification

a)

Position / status

Chief Financial Officer

 

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

MJ Gleeson Plc

 

b)

Legal Entity Identifier code

21380064K7N2W7FD6434

 

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of £0.02 each

GB00BRKD9Z53

b)

Nature of the transaction

Grant of Options over Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

Nil

87,034

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transaction

e)

Date of the transaction

28 October 2024

 

f)

Place of the transaction

Off market

 

 

1.

Details of PDMR / person closely associated with them ('CAP')

a)

First Name

Mark

 

b)

Last Name

Knight

 

2.

Reasons for the notification

a)

Position / status

Chief Executive, Gleeson Homes

 

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

MJ Gleeson Plc

 

b)

Legal Entity Identifier code

21380064K7N2W7FD6434

 

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of £0.02 each

GB00BRKD9Z53

b)

Nature of the transaction

Grant of Options over Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

Nil

53,453

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable- single transaction

e)

Date of the transaction

28 October 2024

 

f)

Place of the transaction

Off market

 

 

1.

Details of PDMR / person closely associated with them ('CAP')

a)

First Name

Leanne

 

b)

Last Name

Johnson

 

2.

Reasons for the notification

a)

Position / status

Company Secretary

 

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

MJ Gleeson Plc

 

b)

Legal Entity Identifier code

21380064K7N2W7FD6434

 

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of £0.02 each

GB00BRKD9Z53

b)

Nature of the transaction

Grant of Options over Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

Nil

4,949

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable- single transaction

e)

Date of the transaction

28 October 2024

 

f)

Place of the transaction

Off market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMMBMTMTIJBBI
Date   Source Headline
12th Feb 20254:14 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSResults for the half year ended 31 December 2024
7th Feb 202511:51 amRNSDirector/PDMR Shareholding
14th Jan 20257:00 amRNSTrading Update & Notice of Results
7th Jan 20254:28 pmRNSDirector/PDMR Shareholding
9th Dec 20244:59 pmRNSDirector/PDMR Shareholding
3rd Dec 20243:50 pmRNSDirector/PDMR Shareholding
26th Nov 20243:34 pmRNSDirector/PDMR Shareholding
15th Nov 20242:08 pmRNSResult of AGM
15th Nov 20247:00 amRNSAGM Trading Update
7th Nov 20242:44 pmRNSDirector/PDMR Shareholding
30th Oct 202410:42 amRNSDirector/PDMR Shareholding
21st Oct 20247:00 amRNSNotice of AGM
18th Oct 20244:24 pmRNSDirector/PDMR Shareholding
18th Oct 20244:19 pmRNSDirector/PDMR Shareholding
9th Oct 20244:27 pmRNSDirector/PDMR Shareholding
4th Oct 202410:18 amRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSAudited results for the year ended 30 June 2024
9th Sep 202410:18 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSTotal Voting Rights
7th Aug 20249:41 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSTotal Voting Rights
23rd Jul 20242:36 pmRNSDirector/PDMR Shareholding
23rd Jul 20241:53 pmRNSStandard form for notification of major holdings
11th Jul 20247:00 amRNSFY2024 Trading Update
8th Jul 20241:34 pmRNSDirector/PDMR Shareholding
8th Jul 20247:00 amRNSNotice of Trading Update
28th Jun 20247:00 amRNSTotal Voting Rights
6th Jun 20242:46 pmRNSDirector/PDMR Shareholding
31st May 20247:00 amRNSTotal Voting Rights
15th May 20247:00 amRNSAppointment of Joint Corporate Broker
9th May 20249:41 amRNSDirector/PDMR Shareholding
30th Apr 20247:00 amRNSTotal Voting Rights
8th Apr 20243:41 pmRNSDirector/PDMR Shareholding
3rd Apr 20244:28 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:28 pmRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTotal Voting Rights
22nd Mar 20249:07 amRNSDirector/PDMR Shareholding
20th Mar 20241:45 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSTotal Voting Rights
26th Feb 20241:04 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSResults for the half year ended 31 December 2023
7th Feb 202411:34 amRNSDirector/PDMR Shareholding
31st Jan 20247:00 amRNSTotal Voting Rights
9th Jan 202410:50 amRNSDirector/PDMR Shareholding
9th Jan 20247:00 amRNSTrading Update & Notice of Results
29th Dec 20237:00 amRNSTotal Voting Rights
15th Dec 20232:49 pmRNSRe Directorate External Appointments
6th Dec 20234:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.